一项关于尼特拉泽帕姆在耐药婴儿性综合征 (NitRIS试验) 疗效的概念验证研究
Parth Lal1, Sandeep Negi1, Kiran Prakash2
1Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pediatric neurology
|October 4, 2025
概括
尼特拉泽在治疗对其他疗法的耐药性婴儿发作综合征 (IESS) 方面比托皮拉更有效. 这项研究发现,尼特拉泽帕姆在患有IESS的儿童中改善了停止,生活质量和自主稳定性.
科学领域:
- 儿科神经学 儿科神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 临床试验 临床试验
背景情况:
- 婴儿发作综合征 (IESS) 治疗在全球范围内有所不同,特别是对于对荷尔蒙和维加巴林疗法耐药的病例.
- 需要对抗抗性IESS的替代抗发作药物进行比较.
研究的目的:
- 为了比较口服尼特拉塞帕姆与口服托皮拉在实现抗性IESS儿童发作 (ES) 完全停止方面的有效性.
- 评估二次结果,包括电临床缓解,生活质量和自主功能.
主要方法:
- 一个开放的,随机对照试验,对40名患有耐药IESS的儿童进行.
- 主要终点:ES完全和持续停止4周,在10周评估.
- 二级终点:电临床缓解,生活质量,心率变化和不良事件.
主要成果:
- 尼特拉泽在55%的患者中实现了完全停止ES,而托皮拉患者则为15% (P=0.019).
- 尼特拉泽帕姆的电临床缓解率更高 (45%对10%,P=0.031).
- 尼特拉泽帕姆显示出更好的生活质量得分和改善的副交感心率变异性; 尼特拉泽帕姆的镇静性更常见,托皮拉玛酸的易怒性更常见.
结论:
- 与托皮拉相比,尼特拉泽在抗性IESS方面显示出更高的短期有效性.
- 尼特拉泽还改善了这一组患者的生活质量和自主稳定性.
- 对尼特拉泽对IESS的长期结果进行进一步的研究是合理的.
相关概念视频
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
822
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
822
01:20Antiepileptic Drugs: Potassium Channel Activators
632
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
632
01:14Antiepileptic Drugs: Glutamate Antagonists
893
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
893
01:24Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.1K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.1K